Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

CHANCES ARE, ONE out of five of you reading this will be diagnosed with skin cancer by the time you hit age 70. As the most ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

The UK is set to bask in 26C temperatures from today with the mercury predicted to soar even further to a potential 32C by ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

A Lampeter cancer nurse and international bowler has been named in the King's Birthday Honours List. Anwen Butten, a Head and ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

A nurse was awarded an MBE in the 2025 King’s Birthday Honours because of her ‘truly inspiring’ work with patients.

"After my cancer diagnosis, I knew the initial assessment had missed everything. " Courtney Liniewski told Newsweek.

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...

Hamad Medical Corporation (HMC) hosted its inaugural Patient Awareness Programme, “Enhancing the Quality of Life of Patients ...